Stemcell United Stock

Stemcell United ROA

The Return on Assets (ROA) of Stemcell United (SCU.AX) as of Sep 8, 2026 is -48.40 %. In the previous year, Return on Assets (ROA) was -30.48 % — a change of 58.79% (lower).

ROA

-48.40 %

YoY

58.79%

Last updated:

In 2026, Stemcell United's return on assets (ROA) was -48.40 %, a 58.79% increase from the -30.48 % ROA in the previous year.

The Stemcell United ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2015
2,095.73 AUD
Jan 1, 2016
-729.72 AUD
Jan 1, 2017
-137.91 AUD
Jan 1, 2018
-212.02 AUD
Jan 1, 2019
-93.19 AUD
Jan 1, 2020
-137.27 AUD
Jan 1, 2021
-30.48 AUD
Jan 1, 2022
-48.40 AUD
The Stemcell United ROA history
YEARROAYoY
-48.40 %+58.79%
-30.48 %-77.80%
-137.27 %+47.30%
-93.19 %-56.05%
-212.02 %+53.73%
-137.91 %-81.10%
-729.72 %-134.82%
2,095.73 %
Access this data via the Eulerpool API

Stemcell United Stock analysis

What does Stemcell United do? Stemcell United Ltd is an internationally operating company that is active in the field of stem cell research and therapy. It was founded in 2005 by British entrepreneur and scientist Dr. Samantha Phillips, who previously worked for the renowned Roslin Institute for Animal Genetics. The business model of Stemcell United is based on the development and distribution of innovative therapies that are based on the use of stem cells as a foundation. The company primarily relies on close collaboration with leading research institutions and clinics worldwide to stay up to date with the latest research and develop products and services that are based on current knowledge and meet the highest quality standards. The various divisions of Stemcell United include the development and production of stem cell-based therapies for diseases such as cancer, heart attack, dementia, and stroke. Additionally, the company also offers support and consultation in the field of clinical trials as well as training for doctors and researchers to improve and optimize the use of stem cell therapies. Another important area of Stemcell United's business activities is the production and marketing of stem cells for research purposes. Both embryonic and adult stem cells are produced and provided to advance research in this field and gain new insights. The products offered by Stemcell United mainly include stem cell preparations for wound healing and tissue regeneration, as well as specialized cell cultures for research in the field of stem cell therapy. These products are sold to clinics, research institutions, and end consumers and are available in many countries worldwide. In recent years, Stemcell United has become one of the leading companies in the field of stem cell research and therapy and enjoys a high reputation in the industry. The company primarily relies on close collaboration with other top companies in the industry and a strong connection to research and development in this field. Overall, Stemcell United is an innovative and dynamic company that sets standards in the field of stem cell research and therapy worldwide and constantly seeks new ways to utilize the possibilities of stem cell therapy for the health and well-being of humans and animals. Stemcell United is one of the most popular companies on Eulerpool.

ROA Details

Understanding Stemcell United's Return on Assets (ROA)

Stemcell United's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Stemcell United's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Stemcell United's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Stemcell United’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Stemcell United stock

Return on Assets (ROA) of Stemcell United is -48.40 % in 2026.

Return on Assets (ROA) of Stemcell United changed from -30.48 % to -48.40 %, representing a 58.79% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) Stemcell United since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s Stemcell United with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

Profitability — Stemcell United

All Key Metrics — Stemcell United